Sanofi to acquire Blueprint Medicines for up to USD 9.5 billion Ruchika Sharma3 Jun 2025 3:23 PM ISTParis: Sanofi and Blueprint Medicines Corporation, a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis...
GSK Linerixibat application for cholestatic pruritus in primary biliary cholangitis patients under USFDA review Ruchika Sharma3 Jun 2025 2:15 PM ISTLondon: GSK plc has announced the New Drug Application (NDA) for linerixibat, an investigational targeted inhibitor of the ileal bile...
GSK Pharma: Chinmay Sharma appointed HRBL, Performance Emerging Markets based out of London; Harsh V Trehan named India HR Head Ruchika Sharma3 Jun 2025 1:01 PM ISTMumbai: GlaxoSmithKline Pharmaceuticals Limited has announced the appointment of Chinmay Sharma, Executive Vice President - Human...
CDSCO approves Biocon diabetes drug Liraglutide Ruchika Sharma3 Jun 2025 11:51 AM ISTLiraglutide is a synthetic analog of GLP-1 peptide and is administered as a once-daily injection.
Granules India Krishnamohan B resigns as Vice President & Head- IT Ruchika Sharma3 Jun 2025 11:15 AM ISTHyderabad: Granules India, a vertically integrated Indian pharmaceutical company, has announced the resignation of Krishnamohan B. from the...
Alembic Pharma gets four USFDA observations for Panelav facility Ruchika Sharma2 Jun 2025 3:03 PM ISTVadodara: Alembic Pharma has announced that the United States Food and Drug Administration (US FDA) has issued four observations after an...
Cipla appoints Prabhakaran Balakrishnan Nair as Global Chief Manufacturing Officer Ruchika Sharma2 Jun 2025 2:40 PM ISTMumbai: Cipla has announced the appointment of Prabhakaran Balakrishnan Nair, presently working as Chief of Quality - Indore plant, as Senior...
CDSCO Panel Approves BE Study for Alkem's Dapagliflozin, Pioglitazone, Metformin FDC, Seeks Revised Phase III Plan Dr. Divya Colin2 Jun 2025 1:51 PM ISTNew Delhi: Alkem Laboratories has received approval from the Subject Expert Committee (SEC) under the Central Drug Standard Control Organisation...
Zydus Lifesciences Rifaximin Tablets bags USFDA tentative nod for irritable bowel syndrome with diarrhoea Ruchika Sharma2 Jun 2025 12:58 PM ISTAhmedabad: Pharma major, Zydus Lifesciences Limited, has received tentative approval from the United States Food and Drug...
USFDA successfully completes inspection at Piramal Pharma Canada facility Ruchika Sharma2 Jun 2025 12:00 PM ISTMumbai: Piramal Pharma Limited has announced that the US Food and Drug Administration (USFDA) has successfully completed inspection...
Cipla (EU), UK incorporates new wholly owned subsidiary in Germany Ruchika Sharma1 Jun 2025 5:48 PM ISTMumbai: Cipla has announced that Cipla (EU) Limited, UK, a wholly owned subsidiary of the Company, has incorporated a new wholly owned subsidiary...
Illegally marketed formulations under name of Biovus Pharma seized at Moosarambagh Ruchika Sharma1 Jun 2025 5:00 PM ISTTelangana: Drugs Control Administration, Telangana has seized illegally marketed formulations under the name of Biovus Pharma, without a drug...
